Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.
about
Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection modelBactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.Relationships between antimicrobial effect and area under the concentration-time curve as a basis for comparison of modes of antibiotic administration: meropenem bolus injections versus continuous infusionsTreatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?Evaluation of pharmacokinetic/pharmacodynamic relationships of PD-0162819, a biotin carboxylase inhibitor representing a new class of antibacterial compounds, using in vitro infection models.Once-daily gentamicin administration for community-associated methicillin resistant Staphylococcus aureus in an in vitro pharmacodynamic model: preliminary reports for the advantages for optimizing pharmacodynamic index.Amikacin Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis in Pediatric Cancer Patients.A novel in vitro pharmacokinetic/pharmacodynamic model based on two-compartment open model used to simulate serum drug concentration-time profiles.
P2860
Q33593883-5A41B27D-DE5A-4825-A99A-EB82C42EB722Q33758399-E49A3B10-9BE6-417D-92C9-6B7DCCD37976Q34922363-ABD0A5EB-1F60-4F6F-9201-7EF7E01B9134Q35131156-403277D9-9587-4A23-A076-21D5C9428D8EQ39783646-404E90E7-F725-464D-89A3-7AD33FB07031Q40068450-AF0C4A1E-0FD7-4E07-8487-20501D1470A9Q40327149-AE7723C9-E592-4683-8879-6D40C16BC1B0Q41877860-1EA972E1-7CDE-429A-804A-35E06604953BQ48528055-28830EF2-5410-4B40-A08A-48D74F5999CBQ51912208-A74F01AB-4F04-47DB-9872-B91F11500203
P2860
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Pharmacodynamic effects of ext ...... ruginosa in an in vitro model.
@ast
Pharmacodynamic effects of ext ...... ruginosa in an in vitro model.
@en
type
label
Pharmacodynamic effects of ext ...... ruginosa in an in vitro model.
@ast
Pharmacodynamic effects of ext ...... ruginosa in an in vitro model.
@en
prefLabel
Pharmacodynamic effects of ext ...... ruginosa in an in vitro model.
@ast
Pharmacodynamic effects of ext ...... ruginosa in an in vitro model.
@en
P2093
P2860
P356
P1476
Pharmacodynamic effects of ext ...... ruginosa in an in vitro model.
@en
P2093
P2860
P304
P356
10.1128/AAC.37.9.1931
P407
P577
1993-09-01T00:00:00Z